Investigating how RNA modifications affect tau protein in Pick's disease

Tau regulation by METTL14-mediated RNA m6A modification in Pick's disease

NIH-funded research Case Western Reserve University · NIH-11116293

This study is looking at how a specific change in RNA might affect the way tau proteins behave in the brain, which could help us understand Pick's disease better and find new ways to treat it.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionCase Western Reserve University NIH-funded
Lab location1 site (Cleveland, United States)
Project IDNIH-11116293 on NIH RePORTER

What this research studies

This research focuses on understanding the role of RNA modifications, specifically N6-methyladenosine (m6A), in the metabolism of tau mRNA and its implications for Pick's disease, a type of neurodegenerative disorder. The researchers will explore how dysregulation of m6A affects tau protein accumulation and aggregation in the brain, which is a hallmark of tauopathies. By studying brain samples from patients, they aim to uncover the mechanisms behind tau-related neurodegeneration and identify potential therapeutic targets.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Pick's disease or other tauopathies.

Not a fit: Patients with neurodegenerative diseases not related to tau pathology may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating or preventing Pick's disease and other tauopathies.

How similar studies have performed: While the role of m6A in neurodegeneration is being explored, this specific investigation into tau mRNA metabolism in Pick's disease is novel and has not been extensively studied.

Where this research is happening

Cleveland, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.